149 related articles for article (PubMed ID: 10955828)
21. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
22. Different roles of p53 between Epstein-Barr virus-positive and -negative gastric carcinomas of matched histology.
Moritani S; Sugihara H; Kushima R; Hattori T
Virchows Arch; 2002 Apr; 440(4):367-75. PubMed ID: 11956816
[TBL] [Abstract][Full Text] [Related]
23. Molecular Grading of Oral Squamous Cell Carcinomas Infected with EBV.
Budhy TI
Asian Pac J Cancer Prev; 2018 Jul; 19(7):1793-1796. PubMed ID: 30049189
[TBL] [Abstract][Full Text] [Related]
24. Co-expression of p53 and Ki67 and lack of EBV expression in oral squamous cell carcinoma.
Iamaroon A; Khemaleelakul U; Pongsiriwet S; Pintong J
J Oral Pathol Med; 2004 Jan; 33(1):30-6. PubMed ID: 14675138
[TBL] [Abstract][Full Text] [Related]
25. p53 expression in oral cancer: observations of a South Indian study.
Pillay M; Vasudevan DM; Rao CP; Vidya M
J Exp Clin Cancer Res; 2003 Sep; 22(3):447-51. PubMed ID: 14582705
[TBL] [Abstract][Full Text] [Related]
26. Epstein Barr virus associated pediatric nasopharyngeal carcinoma: its correlation with p53 and bcl-2 expression.
Preciado MV; Chabay PA; De Matteo EN; Gismondi MI; Rey G; Zubizarreta P
Med Pediatr Oncol; 2002 May; 38(5):345-8. PubMed ID: 11979459
[TBL] [Abstract][Full Text] [Related]
27. Abnormalities of the ARF-p53 pathway in oral squamous cell carcinoma.
Bradley G; Irish J; MacMillan C; Mancer K; Witterick I; Hartwick W; Gullane P; Kamel-Reid S; Benchimol S
Oncogene; 2001 Feb; 20(5):654-8. PubMed ID: 11313998
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus in oral proliferative verrucous leukoplakia and squamous cell carcinoma: A preliminary study.
Bagan JV; Jiménez Y; Murillo J; Poveda R; Díaz JM; Gavaldá C; Margaix M; Scully C; Alberola TM; Torres Puente M; Pérez Alonso M
Med Oral Patol Oral Cir Bucal; 2008 Feb; 13(2):E110-3. PubMed ID: 18223526
[TBL] [Abstract][Full Text] [Related]
29. Comparative analysis of the expression of the Epstein-Barr virus (EBV) anti-apoptotic gene BHRF1 in nasopharyngeal carcinoma and EBV-related lymphoid diseases.
Nicholls J; Kremmer E; Meseda CA; Mackett M; Hahn P; Gulley ML; Brink A; Swinnen LJ; Greenspan J; De Souza Y; Grässer F; Sham J; Ng MH; Arrand JR
J Med Virol; 2001 Sep; 65(1):105-13. PubMed ID: 11505451
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr viral infection in extranodal lymphoma of the head and neck: correlation with prognosis and response to treatment.
Bahnassy AA; Zekri AR; Asaad N; El-Houssini S; Khalid HM; Sedky LM; Mokhtar NM
Histopathology; 2006 Apr; 48(5):516-28. PubMed ID: 16623777
[TBL] [Abstract][Full Text] [Related]
31. The Epstein-Barr virus-associated gastric carcinoma in Southern and Northern China.
Hao Z; Koriyama C; Akiba S; Li J; Luo X; Itoh T; Eizuru Y; Zou J
Oncol Rep; 2002; 9(6):1293-8. PubMed ID: 12375037
[TBL] [Abstract][Full Text] [Related]
32. Relationship between EBV infection and expression of cellular proteins c-Myc, Bcl-2, and Bax in gastric carcinomas.
Lima MA; Ferreira MV; Barros MA; Pardini MI; Ferrasi AC; Mota RM; Rabenhorst SH
Diagn Mol Pathol; 2008 Jun; 17(2):82-9. PubMed ID: 18382371
[TBL] [Abstract][Full Text] [Related]
33. S100A8 is identified as a biomarker of HPV18-infected oral squamous cell carcinomas by suppression subtraction hybridization, clinical proteomics analysis, and immunohistochemistry staining.
Lo WY; Lai CC; Hua CH; Tsai MH; Huang SY; Tsai CH; Tsai FJ
J Proteome Res; 2007 Jun; 6(6):2143-51. PubMed ID: 17451265
[TBL] [Abstract][Full Text] [Related]
34. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
[TBL] [Abstract][Full Text] [Related]
35. Association of Epstein-Barr virus infection with oral squamous cell carcinoma in a case-control study.
Acharya S; Ekalaksananan T; Vatanasapt P; Loyha K; Phusingha P; Promthet S; Kongyingyoes B; Pientong C
J Oral Pathol Med; 2015 Apr; 44(4):252-7. PubMed ID: 25169715
[TBL] [Abstract][Full Text] [Related]
36. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of Epstein-Barr virus involvement in gastric carcinoma in Japan.
Koriyama C; Akiba S; Itoh T; Kijima Y; Sueyoshi K; Corvalan A; Herrera-Goepfer R; Eizuru Y
Int J Mol Med; 2002 Nov; 10(5):635-9. PubMed ID: 12373307
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of p53 in Hodgkin's disease: lack of correlation with Epstein-Barr virus infection.
Niedobitek G; Rowlands DC; Young LS; Herbst H; Williams A; Hall P; Padfield J; Rooney N; Jones EL
J Pathol; 1993 Feb; 169(2):207-12. PubMed ID: 8383196
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus and wild p53 in idiopathic pulmonary fibrosis.
Lok SS; Stewart JP; Kelly BG; Hasleton PS; Egan JJ
Respir Med; 2001 Oct; 95(10):787-91. PubMed ID: 11601742
[TBL] [Abstract][Full Text] [Related]
40. Immunoexpression of cyclooxygenase-2 and p53 in oral squamous cell carcinoma.
Goulart Filho JA; Nonaka CF; da Costa Miguel MC; de Almeida Freitas R; Galvão HC
Am J Otolaryngol; 2009; 30(2):89-94. PubMed ID: 19239949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
